2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
- Font Lavagna, Juan PabloEmployéCHUL+1 418-525-4444, poste 48110juan-pablo.font-lavagna@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Gilbert, ÉmilieStagiaireCHUL+1 418-525-4444, poste 48110emilie.gilbert@crchudequebec.ulaval.ca
2705, boulevard Laurier
R0-709
Québec, QC
Canada G1V 4G2 - Gilbert, ÉmilieEmployéCHUL+1 418-525-4444, poste 48110emilie.gilbert@crchudequebec.ulaval.ca
2705, boulevard Laurier
R0-709
Québec, QC
Canada G1V 4G2 - Gilbert, MéganEmployémegan.gilbert@crchudequebec.ulaval.ca
- Obeyi, GerlinsEmployéCHUL+1 418-525-4444, poste 48110gerlins.obeyi@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Ovyn, ManonStagiaireCHUL+1 418-525-4444manon.ovyn@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Pageau, KimEmployékim.pageau@crchudequebec.ulaval.ca
- Rabezanahary, HenintsoaEmployéCHUL+1 418-525-4444, poste 48110+1 418-654-2715Henintsoa.Rabezanaha@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, Québec
Canada G1V 4G2 - Scarrone, MartinaEmployéCHULmartina.scarrone@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Wantchecon, Croix AudeÉtudiant 2e cycleCHUL+1 418-525-4444, poste 48110aude.wantchecon-croix@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2
A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets
Article de revueJ Virol, 89 (3), 2015.
A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets
Article de revueJ Virol, 89 (13), 2015.
Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets
Article de revueJ Virol, 88 (12), 2014.
Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice
Article de revueAntimicrob Agents Chemother, 58 (11), 2014.
H5N1 vaccines in humans
Article de revueVirus Res, 178 (1), 2013.
Replication and immunogenicity of swine, equine, and avian h3 subtype influenza viruses in mice and ferrets
Article de revueJ Virol, 87 (12), 2013.
Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice
Article de revueClin Vaccine Immunol, 19 (2), 2012.
Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada
Article de revueEmerg Infect Dis, 18 (7), 2012.
Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus
Article de revueClin Vaccine Immunol, 18 (3), 2011.
Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets
Article de revueAntivir Ther, 16 (5), 2011.
Projets actifs
- Fonds de démarrage, Mariana Baz. La grippe à l'interface entre l'homme et l'animal: émergence et contrôle, du 2020-04-13 au 2023-04-12
- Immunité cellulaire et séroprévalence des anticorps contre SARS-COV-2: Caractérisation de trois populations de travailleurs de l'alimentation, du 2020-11-01 au 2023-03-31
- Preclinical proof of concept studies of a new generation of TLR7/8 agonist used in prevention against respiratory viruses and in immunotherapy against lung cancer, du 2023-03-01 au 2024-02-29
Projets terminés récemment
- Effects of high polyphenol doses on the replication of COVID-19 in vitro, du 2020-05-01 au 2021-04-30
- Effects of high polyphenol doses on the replication of COVID-19 in vitro, du 2020-06-01 au 2021-11-30
- Innovative therapeutic approaches for the 2019-novel coronavirus, du 2021-03-01 au 2022-02-28
- Prevention of the immunopathology induced by SARS-CoV-2, du 2021-06-01 au 2022-05-31
- Repositionnement du fumarate de diméthyle pour traiter la COVID-19: une molécule à double action au potentiel antiviral et anti-inflammatoire, du 2020-05-11 au 2021-04-30
- Sex as a Biological Variable Supplement - Innovative therapeutic approaches for the 2019-novel coronavirus, du 2020-05-01 au 2021-03-31
- Understanding the pathogenesis of COVID-19, du 2020-03-01 au 2023-02-28